{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T13:34:46Z","timestamp":1792762486951,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,3,28]],"date-time":"2014-03-28T00:00:00Z","timestamp":1395964800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1007\/s00059-014-4086-1","type":"journal-article","created":{"date-parts":[[2014,3,26]],"date-time":"2014-03-26T09:34:38Z","timestamp":1395826478000},"page":"312-319","source":"Crossref","is-referenced-by-count":16,"title":["Hypoglyk\u00e4mie und Herzrhythmusst\u00f6rungen bei Patienten mit Diabetes Typ 2","Hypoglycemia and cardiac arrhythmia in patients with diabetes mellitus type 2"],"prefix":"10.1007","volume":"39","author":[{"given":"M.","family":"Hanefeld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Ganz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Nolte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,28]]},"reference":[{"key":"4086_CR1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2337\/dc13-0701","volume":"37","author":"Tsujimoto","year":"2014","unstructured":"Tsujimoto T, Yamamoto-Honda R, Kajio H et al (2014) Vital signs, QT prolongation, and newly diagnosed cardiovascular disease during severe hypoglycemia in Type 1 and Type 2 diabetic patients. Diabetes Care 37:217\u2013225","journal-title":"Diabetes Care"},{"key":"4086_CR2","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.2337\/dc09-2082","volume":"33","author":"Desouza","year":"2010","unstructured":"Desouza CV, Bolli GB, Fonseca V (2010) Hypoglycemia, diabetes, and cardiovascular events. Diabetes Care 33:1389\u20131394","journal-title":"Diabetes Care"},{"key":"4086_CR3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pcd.2009.08.007","volume":"3","author":"Graveling","year":"2009","unstructured":"Graveling AJ, Frier BM (2009) Hypoglycaemia: an overview. Prim Care Diabetes 3:131\u2013139","journal-title":"Prim Care Diabetes"},{"key":"4086_CR4","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2337\/dc13-S011","volume":"36","author":"American","year":"2013","unstructured":"American Diabetes Association (2013) Standards of medical care in diabetes \u2013 2013. Diabetes Care 36(Suppl 1):S11\u2013S66","journal-title":"Diabetes Care"},{"key":"4086_CR5","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1001\/jama.2009.496","volume":"301","author":"Kosiborod","year":"2009","unstructured":"Kosiborod M, Inzucchi SE, Goyal A et al (2009) Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction. JAMA 301:1556\u20131564","journal-title":"JAMA"},{"key":"4086_CR6","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.2337\/dc11-2054","volume":"35","author":"McCoy","year":"2012","unstructured":"McCoy RG, Van Houten HK, Ziegenfuss JY et al (2012) Increased mortality of patients with diabetes reporting severe hypoglycemia. Diabetes Care 35:1897\u20131901","journal-title":"Diabetes Care"},{"key":"4086_CR7","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1093\/eurheartj\/eht332","volume":"34","author":"ORIGIN","year":"2013","unstructured":"ORIGIN Trial Investigators, Mellbin LG, Ryd\u00e9n L et al (2013) Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial. Eur Heart J 34:3137\u20133144","journal-title":"Eur Heart J"},{"key":"4086_CR8","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1056\/NEJMoa1003795","volume":"363","author":"Zoungas","year":"2010","unstructured":"Zoungas S, Patel A, Chalmers J et al (2010) Severe hypoglycemia and risks of vascular events and death. N Engl J Med 363:1410\u20131418","journal-title":"N Engl J Med"},{"key":"4086_CR9","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa1006524","volume":"364","author":"ACCORD","year":"2011","unstructured":"ACCORD Study Group, Gerstein HC, Miller ME et al (2011) Long-term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med 364:818\u2013828","journal-title":"N Engl J Med"},{"key":"4086_CR10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","volume":"360","author":"Duckworth","year":"2009","unstructured":"Duckworth W, Abraira C, Moritz T et al (2009) Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 360:129\u2013139","journal-title":"N Engl J Med"},{"key":"4086_CR11","doi-asserted-by":"crossref","first-page":"244","DOI":"10.4158\/EP09260.CR","volume":"16","author":"Tanenberg","year":"2010","unstructured":"Tanenberg RJ, Newton CA, Drake AJ (2010) Confirmation of hypoglycemia in the \u201edead-in-bed\u201c syndrome, as captured by a retrospective continuous glucose monitoring system. Endocr Pract 16:244\u2013248","journal-title":"Endocr Pract"},{"key":"4086_CR12","first-page":"27","volume":"129","author":"Heller","year":"2002","unstructured":"Heller SR (2002) Abnormalities of the electrocardiogram during hypoglycaemia: the cause of the dead in bed syndrome? Int J Clin Pract Suppl 129:27\u201332","journal-title":"Int J Clin Pract Suppl"},{"key":"4086_CR13","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.2337\/diacare.26.5.1485","volume":"26","author":"Desouza","year":"2003","unstructured":"Desouza C, Salazar H, Cheong B et al (2003) Association of hypoglycemia and cardiac ischemia: a study based on continuous monitoring. Diabetes Care 26:1485\u20131489","journal-title":"Diabetes Care"},{"key":"4086_CR14","doi-asserted-by":"crossref","first-page":"516","DOI":"10.2337\/dc13-0600","volume":"37","author":"Stahn","year":"2014","unstructured":"Stahn A, Pistrosch F, Ganz X et al (2014) Relationship between hypoglycemic episodes and ventricular arrhythmias in patients with type 2 diabetes and cardiovascular diseases: silent hypoglycemias and silent arrhythmias. Diabetes Care 37:516\u2013520","journal-title":"Diabetes Care"},{"key":"4086_CR15","doi-asserted-by":"crossref","first-page":"S132","DOI":"10.2337\/dc11-s220","volume":"34","author":"Frier","year":"2011","unstructured":"Frier BM, Schernthaner G, Heller SR (2011) Hypoglycemia and cardiovascular risks. Diabetes Care 34(Suppl 2):S132\u2013S137","journal-title":"Diabetes Care"},{"key":"4086_CR16","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1464-5491.2007.02341.x","volume":"25","author":"Amiel","year":"2008","unstructured":"Amiel SA, Dixon T, Mann R, Jameson K (2008) Hypoglycaemia in Type 2 diabetes. Diabet Med 25:245\u2013254","journal-title":"Diabet Med"},{"key":"4086_CR17","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/BF00275756","volume":"30","author":"Fisher","year":"1987","unstructured":"Fisher BM, Gillen G, Dargie HJ et al (1987) The effects of insulin-induced hypoglycaemia on cardiovascular function in normal man: studies using radionuclide ventriculography. Diabetologia 30:841\u2013845","journal-title":"Diabetologia"},{"key":"4086_CR18","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/(SICI)1096-9136(199708)14:8<648::AID-DIA418>3.0.CO;2-1","volume":"14","author":"Marques","year":"1997","unstructured":"Marques JL, George E, Peacey SR et al (1997) Altered ventricular repolarization during hypoglycemia in patients with diabetes. Diabet Med 14:648\u2013654","journal-title":"Diabet Med"},{"key":"4086_CR19","doi-asserted-by":"crossref","first-page":"360","DOI":"10.2337\/db08-1153","volume":"58","author":"Adler","year":"2009","unstructured":"Adler GK, Bonyhay I, Failing H et al (2009) Antecedent hypoglycemia impairs autonomic cardiovascular function: implications for rigorous glycemic control. Diabetes 58:360\u2013366","journal-title":"Diabetes"},{"key":"4086_CR20","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.2337\/dc09-2082","volume":"33","author":"Desouza","year":"2010","unstructured":"Desouza CV, Bolli GB, Fonseca V (2010) Hypoglycemia, diabetes, and cardiovascular events. Diabetes Care 33:1389\u20131394","journal-title":"Diabetes Care"},{"key":"4086_CR21","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/BF00401055","volume":"36","author":"Ceriello","year":"1993","unstructured":"Ceriello A (1993) Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects. Diabetologia 36:1119\u20131125","journal-title":"Diabetologia"},{"key":"4086_CR22","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1002\/(SICI)1096-9136(199708)14:3+<S45::AID-DIA444>3.3.CO;2-I","volume":"14","author":"Ceriello","year":"1997","unstructured":"Ceriello A (1997) Acute hyperglycaemia and oxidative stress generation. Diabet Med 14(Suppl 3):S45\u2013S49","journal-title":"Diabet Med"},{"key":"4086_CR23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/heartjnl-2011-300503","volume":"98","author":"Huxley","year":"2012","unstructured":"Huxley RR, Alonso A, Lopez FL et al (2012) Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: the Atherosclerosis Risk in Communities study. Heart 98:133\u2013138","journal-title":"Heart"},{"key":"4086_CR24","first-page":"23","volume":"Med","author":"Panova","year":"2008","unstructured":"Panova EI, Kruglova NE (2008) Factors associated with cardiac arrhythmias in patients with type 2 diabetes mellitus and myocardial infarction. Klin Med (Mosk) 86:23\u201326","journal-title":"Klin"},{"key":"4086_CR25","first-page":"S102","volume":"55","author":"Pochinka","year":"2012","unstructured":"Pochinka I, Strongin L, Struchkova J (2012) Glycaemic variability and ventricular cardiac arrhythmias in type 2 diabetic patients with chronic heart failure. 48th EASD Annual Meeting of the European Association for the Study of Diabetes, Abstr 230. Diabetologia 55(Suppl 1):S102","journal-title":"Diabetologia"},{"key":"4086_CR26","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/SLA.0b013e31822c5d78","volume":"254","author":"Lazar","year":"2011","unstructured":"Lazar HL, McDonnell MM, Chipkin S et al (2011) Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Ann Surg 254:458\u2013463","journal-title":"Ann Surg"},{"key":"4086_CR27","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1177\/193229680800200618","volume":"2","author":"Monnier","year":"2008","unstructured":"Monnier L, Colette C, Owens DR (2008) Glycemic variability: the third component of the dysglycemia in diabetes. Is it important? How to measure it? J Diabetes Sci Technol 2:1094\u20131100","journal-title":"J Diabetes Sci Technol"},{"key":"4086_CR28","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.2337\/diacare.24.10.1793","volume":"24","author":"Gerritsen","year":"2001","unstructured":"Gerritsen J, Dekker JM, TenVoorde BJ et al (2001) Impaired autonomic function is ssociated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: the Hoorn Study. Diabetes Care 24:1793\u20131798","journal-title":"Diabetes Care"},{"key":"4086_CR29","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.1016\/j.diabres.2008.09.026","volume":"82","author":"Heller","year":"2008","unstructured":"Heller SR (2008) Hypoglycemia in Type 2 diabetes. Diabetes Res Clin Pract 82(Suppl 2):S108\u2013S111","journal-title":"Diabetes Res Clin Pract"},{"key":"4086_CR30","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/dmrr.865","volume":"24","author":"Wright","year":"2008","unstructured":"Wright RJ, Frier BM (2008) Vascular disease and diabetes: is hypoglycaemia an aggravating factor? Diabetes Metab Res Rev 24:353\u2013363","journal-title":"Diabetes Metab Res Rev"},{"key":"4086_CR31","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF01235856","volume":"17","author":"Clarke","year":"1979","unstructured":"Clarke BF, Ewing DJ, Campbell IW (1979) Diabetic autonomic neuropathy. Diabetologia 17:195\u2013212","journal-title":"Diabetologia"},{"key":"4086_CR32","first-page":"255","volume":"47","author":"Psallas","year":"2006","unstructured":"Psallas M, Tentolouris N, Cokkinos A et al (2006) QT dispersion: comparison between diabetic and non-diabetic individuals and correlation with cardiac autonomic neuropathy. Hellenic J Cardio 47:255\u2013262","journal-title":"Hellenic J Cardio"},{"key":"4086_CR33","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1365-2796.1999.00528.x","volume":"246","author":"Landstedt-Hallin","year":"1999","unstructured":"Landstedt-Hallin L, Englund A, Adamson U, Lins PE (1999) Increased QT dispersion during hypoglycaemia in patients with type 2 diabetes mellitus. J Intern Med 246:299\u2013307","journal-title":"J Intern Med"},{"key":"4086_CR34","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00125-012-2534-0","volume":"55","author":"Inzucchi","year":"2012","unstructured":"Inzucchi SE, Bergenstal RM, Buse JB et al (2012) Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 55:1577\u20131596","journal-title":"Diabetologia"},{"key":"4086_CR35","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.2337\/dc13-S004","volume":"36","author":"o","year":"2013","unstructured":"o A (2013) Executive summary: standards of medical care in diabetes \u2013 2013. Diabetes Care 36(Suppl 1):S4\u2013S10","journal-title":"Diabetes Care"},{"key":"4086_CR36","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2337\/dc13-2116","volume":"37","author":"Lachin","year":"2014","unstructured":"Lachin JM, Orchard TJ, Nathan DM; DCCT\/EDIC Research Group (2014) Update on cardiovascular outcomes at 30 years of the diabetes control and complications trial\/epidemiology of diabetes interventions and complications study. Diabetes Care 37:39\u201343","journal-title":"Diabetes Care"},{"key":"4086_CR37","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1056\/NEJMoa1305889","volume":"369","author":"White","year":"2013","unstructured":"White WB, Cannon CP, Heller SR et al (2013) Alogliptin after acute coronary syndrome in patients with type 2 diabetes. N Engl J Med 369:1327\u20131335","journal-title":"N Engl J Med"},{"key":"4086_CR38","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0140-6736(05)67528-9","volume":"366","author":"Dormandy","year":"2005","unstructured":"Dormandy JA, Charbonnel B, Eckland DJ; PROactive investigators (2005) Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet 366:1279\u20131289","journal-title":"Lancet"},{"key":"4086_CR39","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1093\/eurheartj\/eht332","volume":"34","author":"ORIGIN","year":"2013","unstructured":"ORIGIN Trial Investigators, Mellbin LG, Ryd\u00e9n L et al (2013) Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial. Eur Heart J 34:3137\u20133144","journal-title":"Eur Heart J"},{"key":"4086_CR40","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa1307684","volume":"369","author":"Scirica","year":"2013","unstructured":"Scirica BM, Bhatt DL, Braunwald E; SAVOR-TIMI 53 Steering Committee and Investigators (2013) Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. N Engl J Med 369:1317\u20131326","journal-title":"N Engl J Med"},{"key":"4086_CR41","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","volume":"352","author":"UK","year":"1998","unstructured":"UK Prospective Diabetes Study (UKPDS) Group (1998) Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352:854\u2013865","journal-title":"Lancet"},{"key":"4086_CR42","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","volume":"352","author":"UK","year":"1998","unstructured":"UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837\u2013853","journal-title":"Lancet"},{"key":"4086_CR43","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJMe0807625","volume":"359","author":"Chalmers","year":"2008","unstructured":"Chalmers J, Cooper ME (2008) UKPDS and the legacy effect. N Engl J Med 359:1618\u20131620","journal-title":"N Engl J Med"},{"key":"4086_CR44","doi-asserted-by":"crossref","first-page":"S303","DOI":"10.1016\/j.ejim.2009.05.012","volume":"20","author":"Nauck","year":"2009","unstructured":"Nauck MA (2009) Unraveling the science of incretin biology. Eur J Intern Med 20(Suppl 2):S303\u2013S308","journal-title":"Eur J Intern Med"},{"key":"4086_CR45","doi-asserted-by":"crossref","unstructured":"Meier JJ, Schmidt WE, Klein HH (2007) New concepts in the treatment of type 2 diabetes. Internist (Berl) 48:698, 700\u2013707","DOI":"10.1007\/s00108-007-1876-z"},{"key":"4086_CR46","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0735-1097(98)00557-9","volume":"33","author":"Garratt","year":"1999","unstructured":"Garratt KN, Brady PA, Hassinger NL et al (1999) Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction. J Am Coll Cardiol 33:119\u2013124","journal-title":"J Am Coll Cardiol"},{"key":"4086_CR47","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.metabol.2012.12.003","volume":"62","author":"Soydan","year":"2013","unstructured":"Soydan N, Bretzel RG, Fischer B et al (2013) Reduced capacity of heart rate regulation in response to mild hypoglycemia induced by glibenclamide and physical exercise in type 2 diabetes. Metabolism 62:717\u2013724","journal-title":"Metabolism"},{"key":"4086_CR48","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1530\/eje.0.1400004","volume":"140","author":"Lopez-Liuchi","year":"1999","unstructured":"Lopez-Liuchi JV, Meier CA (1999) Therapy for type 2 diabetes: where do we stand after the UK prospective diabetes study? Eur J Endocrinol 140:4\u20136","journal-title":"Eur J Endocrinol"},{"key":"4086_CR49","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1111\/j.1464-5491.2012.03772.x","volume":"29","author":"Juurlink","year":"2012","unstructured":"Juurlink DN, Gomes T, Shah BR, Mamdani MM (2012) Adverse cardiovascular events during treatment with glyburide (glibenclamide) or gliclazide in a high-risk population. Diabet Med 29:1524\u20131528","journal-title":"Diabet Med"},{"key":"4086_CR50","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1007\/s00125-011-2084-x","volume":"54","author":"Mellbin","year":"2011","unstructured":"Mellbin LG, Malmberg K, Norhammar A et al (2011) Prognostic implications of glucose-lowering treatment in patients with acute myocardial infarction and diabetes: experiences from an extended follow-up of the Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) 2 Study. Diabetologia 54:1308\u20131317","journal-title":"Diabetologia"},{"key":"4086_CR51","doi-asserted-by":"crossref","unstructured":"Matsumoto T, Lopes RA, Taguchi K et al (2014) Linking the beneficial effects of current therapeutic approaches in diabetes to the vascular endothelin system. Life Sci [Epub ahead of print]","DOI":"10.1016\/j.lfs.2013.12.216"},{"key":"4086_CR52","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/dmrr.1174","volume":"27","author":"Monnier","year":"2011","unstructured":"Monnier L, Colette C, Michel F et al (2011) Insulin therapy has a complex relationship with measure of oxidative stress in type 2 diabetes: a case for further study. Diabetes Metab Res Rev 27:348\u2013353","journal-title":"Diabetes Metab Res Rev"},{"key":"4086_CR53","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2337\/diacare.29.01.06.dc05-0955","volume":"29","author":"Scognamiglio","year":"2006","unstructured":"Scognamiglio R, Negut C, Kreutzenberg SV de et al (2006) Effects of different insulin regimes on postprandial myocardial perfusion defects in type 2 diabetic patients. Diabetes Care 29:95\u2013100","journal-title":"Diabetes Care"},{"key":"4086_CR54","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1055\/s-0030-1262874","volume":"119","author":"Engler","year":"2011","unstructured":"Engler B, Koehler C, Hoffmann C et al (2011) Relationship between HbA1c on target, risk of silent hypoglycemia and glycemic variability in patients with type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 119:59\u201361","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"4086_CR55","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1464-5491.2009.02915.x","volume":"27","author":"Hanefeld","year":"2010","unstructured":"Hanefeld M, Koehler C, Hoffmann C et al (2010) Effect of targeting normal fasting glucose levels with basal insulin glargine on glycaemic variability and risk of hypoglycaemia: a randomized, controlled study in patients with early Type 2 diabetes. Diabet Med 27:175\u2013180","journal-title":"Diabet Med"},{"key":"4086_CR56","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1463-1326.2011.01412.x","volume":"13","author":"Fonseca","year":"2011","unstructured":"Fonseca V, Gill J, Zhou R, Leahy J (2011) An analysis of early insulin glargine added to metformin with or without sulfonylurea: impact on glycaemic control and hypoglycaemia. Diabetes Obes Metab 13:814\u2013822","journal-title":"Diabetes Obes Metab"},{"key":"4086_CR57","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1056\/NEJMoa0905479","volume":"361","author":"Holman","year":"2009","unstructured":"Holman RR, Farmer AJ, Davies MJ et al (2009) Three-year efficacy of complex insulin regimens in type 2 diabetes. N Engl J Med 361:1736\u20131747","journal-title":"N Engl J Med"},{"key":"4086_CR58","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.2337\/diacare.26.11.3080","volume":"26","author":"Riddle","year":"2003","unstructured":"Riddle MC, Rosenstock J, Gerich J; Insulin Glargine 4002 Study Investigators (2003) The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care 26:3080\u20133086","journal-title":"Diabetes Care"},{"key":"4086_CR59","doi-asserted-by":"crossref","unstructured":"Laubner K, Molz K, Kerner W et al (2013) Daily insulin doses and injection frequencies of Neutral Protamine Hagedorn (NPH) insulin, insulin detemir and glargine in type 1 and type 2 diabetes: a multicenter analysis of 51 964 patients from the German\/Austrian DPV-Wiss database. Diabetes Metab Res Rev [Epub ahead of print]","DOI":"10.1002\/dmrr.2500"},{"key":"4086_CR60","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S0140-6736(08)60485-7","volume":"371","author":"Bretzel","year":"2008","unstructured":"Bretzel RG, Nuber U, Landgraf W et al (2008) Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial. Lancet 371:1073\u20131084","journal-title":"Lancet"},{"key":"4086_CR61","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2337\/diacare.28.2.254","volume":"28","author":"Janka","year":"2005","unstructured":"Janka HU, Plewe G, Riddle MC et al (2005) Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes. Diabetes Care 28:254\u2013259","journal-title":"Diabetes Care"}],"container-title":["Herz"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-014-4086-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00059-014-4086-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-014-4086-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T19:04:07Z","timestamp":1565291047000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00059-014-4086-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,28]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["4086"],"URL":"https:\/\/doi.org\/10.1007\/s00059-014-4086-1","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,28]]}}}